BRIEF-Contango Announces Acquisition Of HighGold-March 2024-www.financetom.com

BRIEF-Contango Announces Acquisition Of HighGold

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Contango Announces Acquisition Of HighGold

May 2, 2024 3:38 AM

May 2 (Reuters) - Contango ORE Inc ( CTGO ):

* CONTANGO ANNOUNCES ACQUISITION OF HIGHGOLD

* CONTANGO ORE INC ( CTGO ) - UNDER TERMS OF AGREEMENT, EACH HIGHGOLD

("HIGHGOLD SHARE") WILL BE EXCHANGED FOR 0.019 SHARES OF

CONTANGO COMMON STOCK

* CONTANGO ORE INC ( CTGO )- PROPOSED DEAL FOR APPROXIMATELY US$37

MILLION

Source text for Eikon:

Further company coverage:

([email protected])

Previous page： Expense management software firm Expensify Q3 revenue misses estimates Next page： Iris Energy Q1 net income swings to profit

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Expense management software firm Expensify Q3 revenue misses estimates

Nov 6, 2025

Overview * Expensify ( EXFY ) Q3 revenue fell 1% yr/yr, missing analyst expectations * Interchange revenue from Expensify Card grew 18% yr/yr * Company repurchased 1.58 mln shares, totaling $3.0 mln Outlook * Expensify ( EXFY ) estimates FY25 free cash flow between $19.0 mln and $23.0 mln Result Drivers * INTERCHANGE REVENUE - Expensify Card interchange revenue grew...

Iris Energy Q1 net income swings to profit

Nov 6, 2025

Overview * Iris Energy Q1 FY26 rev grows 355% yr/yr to $240.3 mln * Net income for Q1 FY26 rises to $384.6 mln from a loss last year * Pretax profit for Q1 FY26 beats analyst expectations Outlook * Iris Energy targets $3.4 bln AI Cloud ARR by end of 2026 * Company expects $1.9 bln ARR from Microsoft contract...

Canadian eyewear retailer Kits Eyecare's Q3 revenue rises 25%

Nov 6, 2025

Overview * Kits Eyecare ( KTYCF ) Q3 revenue rises 25.1% yr/yr to all-time high of C$52.4 mln * Adjusted EBITDA for Q3 improves 79% to C$2.9 mln * Net income for Q3 surges to C$1.9 mln, up 1,367.4% yr/yr Outlook * Kits Eyecare expects Q4 2025 revenue between C$52 mln and C$54 mln * Company anticipates Q4 2025 adjusted...

Rocket Pharmaceuticals Q3 net loss narrows

Nov 6, 2025

Overview * Rocket Pharmaceuticals ( RCKT ) reports Q3 net loss of $50.3 mln, reduced from prior year * R&D and G&A expenses decreased due to disciplined resource allocation * Company to resume pivotal Phase 2 trial for Danon disease in 1H 2026 Outlook * Rocket expects cash resources to fund operations into Q2 2027 * Company anticipates dosing additional...